Arbutus Biopharma Corp (ABUS) SEC Filings — 2025
20 SEC filings for Arbutus Biopharma Corp (ABUS) in 2025.
Filings
- Arbutus Biopharma Corp 8-K Filing — 8-K · Dec 11, 2025
- Arbutus Biopharma Corp 8-K Filing — 8-K · Nov 13, 2025
- Arbutus Narrows Losses by 48% on Soaring Revenue, Cost Cuts — 10-Q · Nov 13, 2025
- Arbutus Biopharma Files 8-K — 8-K · Oct 7, 2025
- Arbutus Biopharma Corp. Files 8-K — 8-K · Sep 10, 2025
- Arbutus Biopharma Files 8-K on Operations and Personnel — 8-K · Aug 6, 2025
- Arbutus Biopharma Q2 Loss Widens Amid Rising R&D Costs — 10-Q · Aug 6, 2025
- Arbutus Biopharma Terminates Material Definitive Agreement — 8-K · Jun 25, 2025
- Arbutus Biopharma Files 8-K on Shareholder Vote Matters — 8-K · May 23, 2025
- Arbutus Biopharma Files 8-K on Operations and Financials — 8-K · May 14, 2025
- Arbutus Biopharma Corp 10-Q Filing — 10-Q · May 14, 2025
- Arbutus Biopharma Files 8-K — 8-K · May 7, 2025
- Arbutus Biopharma Files 8-K — 8-K · Apr 23, 2025
- Arbutus Biopharma Files Definitive Proxy Statement — DEF 14A · Apr 4, 2025
- Arbutus Biopharma Corp. Announces Board and Executive Changes — 8-K · Apr 3, 2025
- Arbutus Biopharma Files 8-K on Financials — 8-K · Mar 27, 2025
- Arbutus Biopharma Files 2024 10-K — 10-K · Mar 27, 2025
- Arbutus Biopharma Corp Files 8-K Report — 8-K · Mar 3, 2025
- Arbutus Biopharma Corp Files 8-K on Director/Officer Changes — 8-K · Feb 25, 2025
- Arbutus Biopharma Files 8-K — 8-K · Jan 13, 2025